StreetInsider.com News Articles

High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

Wed, 17 Jun 2026 06:00:00 -0400

CALGARY, AB, June 17, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its majority-owned subsidiary, Remexian Pharma GmbH ("Remexian"), showcased its exclusive German medical cannabis distribution partnerships with leading Canadian cannabis brands at Mary Jane Berlin 2026, one of Europe's largest cannabis trade shows, held June 11–14, 2026, in Berlin, Germany. Through these partnerships, Remexian is bringing premium Canadian medical cannabis products to

High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

Wed, 17 Jun 2026 06:00:00 -0400

High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

Wed, 17 Jun 2026 06:00:00 -0400

High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

Wed, 17 Jun 2026 06:00:00 -0400

High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

Wed, 17 Jun 2026 06:00:00 -0400

High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

Wed, 17 Jun 2026 06:00:00 -0400

High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

Wed, 17 Jun 2026 06:00:00 -0400

High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

Wed, 17 Jun 2026 06:00:00 -0400

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income

The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%

The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

Mon, 15 Jun 2026 16:00:00 -0400

The Company Also Reports Positive Free Cash Flow and Net Income
The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%
The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth
Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year
ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year
High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,¹ and